[Zrytec drops in the treatment of allergy rhinitis in children]

J Y Tang1

  • 1Ninth People's Hospital, Shanghai 200011.

Lin Chuang Er Bi Yan Hou Ke Za Zhi = Journal of Clinical Otorhinolaryngology
|February 5, 2003
PubMed

Insights

Zyrtec (Cetirizine 2 HCL) drops effectively treat allergy rhinitis in children. This study found significant symptom improvement and good tolerance in young patients.

Area of Science:

  • Pediatric Allergy and Immunology
  • Pharmacology and Therapeutics

Background:

  • Allergic rhinitis (AR) is a common condition in children.
  • Effective and safe treatment options are crucial for managing pediatric AR.

Purpose of the Study:

  • To evaluate the efficacy and safety of Zyrtec (Cetirizine 2 HCL) drops for treating allergy rhinitis in children.
  • To assess the clinical effectiveness and tolerability of Zyrtec drops in a pediatric population.

Main Methods:

  • A randomized study included 47 children aged 2-6 years with AR.
  • Participants received Zyrtec (Cetirizine 2 HCL) drops 5 mg daily for 3 weeks.
  • Symptom scores were evaluated weekly to assess treatment response.

Main Results:

  • Statistically significant improvement in allergy rhinitis symptoms was observed weekly (P < 0.01).
  • Zyrtec drops demonstrated excellent efficacy by the study's end.
  • The treatment showed good tolerance among the pediatric participants.

Conclusions:

  • Zyrtec drops are a highly effective treatment for pediatric allergic rhinitis.
  • The medication offers rapid action, potency, good tolerance, and ease of use.
  • Zyrtec drops represent a beneficial therapeutic option for children with AR.
Abstract